Autolus Therapeutics (AUTL)
(Delayed Data from NSDQ)
$4.06 USD
+0.15 (3.84%)
Updated Oct 8, 2024 04:00 PM ET
After-Market: $4.06 0.00 (0.00%) 7:28 PM ET
4-Sell of 5 4
F Value D Growth C Momentum F VGM
Autolus Therapeutics PLC Sponsored ADR (AUTL) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$9.70 | $12.00 | $6.90 | 148.08% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for Autolus Therapeutics PLC Sponsored ADR comes to $9.70. The forecasts range from a low of $6.90 to a high of $12.00. The average price target represents an increase of 148.08% from the last closing price of $3.91.
Analyst Price Targets (7 )
Broker Rating
Autolus Therapeutics PLC Sponsored ADR currently has an average brokerage recommendation (ABR) of 1.38 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 1.38 a month ago based on eight recommendations.
Of the eight recommendations deriving the current ABR, six are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 75% and 12.5% of all recommendations. A month ago, Strong Buy made up 75%, while Buy represented 12.5%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 6 | 6 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.38 | 1.38 | 1.38 | 1.38 | 1.38 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/9/2024 | Truist Securities | Asthika S Goonewardene | Strong Buy | Strong Buy |
8/8/2024 | Wells Fargo Securities | Yanan Zhu | Strong Buy | Strong Buy |
6/28/2024 | Goldman Sachs | Rajan Sharma | Hold | Hold |
6/17/2024 | Needham & Company | Gil J Blum | Moderate Buy | Moderate Buy |
6/3/2024 | William Blair | Matt Phipps | Strong Buy | Strong Buy |
2/13/2024 | Mizuho SecuritiesUSA | Salim Syed | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.38 |
ABR (Last week) | 1.38 |
# of Recs in ABR | 8 |
Average Target Price | $9.70 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 76 of 252 |
Current Quarter EPS Est: | -0.21 |
AUTL FAQs
Autolus Therapeutics PLC Sponsored ADR (AUTL) currently has an average brokerage recommendation (ABR) of 1.38 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 8 brokerage firms.
The average price target for Autolus Therapeutics PLC Sponsored ADR (AUTL) is $9.70. The current on short-term price targets is based on 4 reports.
The forecasts for Autolus Therapeutics PLC Sponsored ADR (AUTL) range from a low of $6.9 to a high of $12. The average price target represents a increase of $148.08 from the last closing price of $3.91.
The current UPSIDE for Autolus Therapeutics PLC Sponsored ADR (AUTL) is 148.08%
Based on short-term price targets offered by seven analysts, the average price target for Autolus Therapeutics PLC Sponsored ADR comes to $9.70. The forecasts range from a low of $6.90 to a high of $12.00. The average price target represents an increase of 148.08% from the last closing price of $3.91.